T. Rowe Price Investment Management, Inc. Immunocore Holdings PLC Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 7,067,659 shares of IMCR stock, worth $225 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
7,067,659
Previous 7,051,818
0.22%
Holding current value
$225 Million
Previous $209 Million
6.0%
% of portfolio
0.14%
Previous 0.14%
Shares
7 transactions
Others Institutions Holding IMCR
# of Institutions
145Shares Held
45.1MCall Options Held
297KPut Options Held
1.17M-
Rtw Investments, LP New York, NY4.87MShares$155 Million2.35% of portfolio
-
Wellington Management Group LLP Boston, MA4.21MShares$134 Million0.03% of portfolio
-
Primecap Management CO Pasadena, CA3.77MShares$120 Million0.1% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.44MShares$77.8 Million1.74% of portfolio
-
Baker Bros. Advisors LP New York, NY2.32MShares$74 Million0.74% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.4B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...